Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00286416|
Recruitment Status : Unknown
Verified January 2006 by Scripps Health.
Recruitment status was: Recruiting
First Posted : February 3, 2006
Last Update Posted : November 7, 2006
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Study Completion Date :||July 2008|
Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol. 2003 Apr;24(2):159-68. Review.